Octarine Bio

Copenhagen, Denmark

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

$5.9M raised

Jan 2026

Series A

Top Investors

The Footprint FirmUnconventional VenturesVaekstfondenMassChallengeEdaphon

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Octarine Bio raised?

Octarine Bio has raised $5.9M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Octarine Bio's investors?

Octarine Bio's investors include The Footprint Firm, Unconventional Ventures, Vaekstfonden, MassChallenge, Edaphon.

Where is Octarine Bio headquartered?

Octarine Bio is headquartered in Copenhagen, Denmark.

What does Octarine Bio do?

Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.

What stage is Octarine Bio at?

Octarine Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 22, 2026.

MLA

"Octarine Bio — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/octarine-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Octarine Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/octarine-bio

Wikipedia (cite web)

{{cite web |title=Octarine Bio — Funding & Investors |url=https://www.vcbacked.co/company/octarine-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 22, 2026.